| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 08/08/2012 | EP2484373A1 High frequency application of botulinum toxin therapy |
| 08/08/2012 | EP2483300A1 Synthetic myostatin peptide antagonists |
| 08/08/2012 | EP2066680B1 Triphenylphosphonium thionitrite nitric oxide donors |
| 08/08/2012 | EP1169038B1 Cyclic protein tyrosine kinase inhibitors |
| 08/08/2012 | CN102626447A Preparation method of kava lactone |
| 08/08/2012 | CN101961418B Double-controlled release, high-dosage and low-irritation capsaicin compound transdermal patch |
| 08/07/2012 | US8236804 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 08/07/2012 | US8236803 Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists |
| 08/07/2012 | US8236798 Carboxamide compounds and their use as calpain inhibitors |
| 08/02/2012 | WO2012100408A1 Dextrin inclusion complex, preparation method thereof and pharmaceutical formulation comprising said inclusion complex |
| 08/02/2012 | WO2012100389A1 Triterpenoid saponin compounds, preparation methods and uses thereof |
| 08/02/2012 | US20120196934 Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form and a surfactant, and methods and uses thereof |
| 08/02/2012 | US20120196933 Mexiletine prodrugs |
| 08/02/2012 | US20120196929 Use of Rosmarinic Acid and the Derivaties Thereof to Treat Ciguatera |
| 08/02/2012 | US20120196895 Novel forms of eperisone |
| 08/02/2012 | US20120196869 Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels |
| 08/02/2012 | US20120196863 1,4 oxazines as bace1 and/or bace2 inhibitors |
| 08/02/2012 | US20120196855 Oxygen linked pyrimidine derivatives |
| 08/02/2012 | US20120196854 Pharmaceutical composition comprising aromatic heterocyclic compound |
| 08/02/2012 | US20120196837 Method of treating frailty |
| 08/02/2012 | US20120196818 Method for preparing polyphenol extracts from spinach leaves |
| 08/02/2012 | US20120196789 Peptide based peroxidase inhibitors and methods of using same |
| 08/02/2012 | US20120195985 Glycine transporter-1 inhibitors |
| 08/02/2012 | US20120195963 Highly purified ethyl epa and other epa derivatives |
| 08/02/2012 | US20120195896 Igf-1 fusion polypeptides and therapeutic uses thereof |
| 08/02/2012 | US20120195892 Immunoglobulin molecules with improved characteristics |
| 08/02/2012 | US20120195873 Methods of attenuating the loss of functional status |
| 08/01/2012 | EP2155201B1 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases |
| 08/01/2012 | EP1328653B1 Highly expressible genes |
| 08/01/2012 | CN102625804A Compounds useful for treating AIDS |
| 08/01/2012 | CN102617462A Specificity inhibition muscle micro ribonucleic acid compound and synthesis method and application thereof |
| 08/01/2012 | CN102614347A Chinese medicine for treating chronic lumbar strain |
| 08/01/2012 | CN102614261A Traditional Chinese medicine applied on umbilical region for treating hiccup |
| 07/31/2012 | US8232383 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 07/31/2012 | CA2489965C Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 07/31/2012 | CA2458471C Prostaglandin analogs as chloride channel opener |
| 07/26/2012 | WO2012100050A1 A composition for the attachment of implants to collagen or other components of biological tissue |
| 07/26/2012 | WO2012098387A1 6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors |
| 07/26/2012 | US20120190717 Methods and compositions for increasing the anaerobic working capacity in tissues |
| 07/26/2012 | US20120190716 Methods and uses of cytochrome p450 inhibitors |
| 07/26/2012 | US20120190634 Lipoteichoic acid-derived glycolipids, and compositions comprising same |
| 07/26/2012 | US20120190617 Niacin and/or trigonelline as a muscle stimulant |
| 07/26/2012 | US20120190616 Analogues of Insulin-Like Growth Factor-1 (IGF-1) Having Amino Acid Substitution at Position 59 |
| 07/26/2012 | US20120189717 Method of using beta-hydroxy-beta-methylbutyrate and fatty acids for treating disease-associated wasting |
| 07/26/2012 | US20120189693 Oral dosage forms |
| 07/26/2012 | US20120189667 Method for repairing or replacing damaged tissue |
| 07/26/2012 | US20120189613 Stim2-mediated capacitive calcium entry |
| 07/26/2012 | US20120189597 Nutritional compositions including exogenous nucleotides |
| 07/26/2012 | US20120189587 Cell sheet for tissue repair and bio-artificial tissue engineering, method of producing the same and method of using the same |
| 07/25/2012 | EP2477622A1 Compositions and methods for treating spasticity |
| 07/25/2012 | EP1257544B1 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage |
| 07/25/2012 | EP1109453B1 Compositions and methods for treatment of mitochondrial diseases |
| 07/25/2012 | CN102612524A Dual variable domain immunoglobulins and uses thereof |
| 07/25/2012 | CN102604951A Compositions and methods to treat muscular & cardiovascular disorders |
| 07/25/2012 | CN102604916A Induction of gene expression using a high concentration sugar mixture |
| 07/25/2012 | CN102603734A Protein kinase inhibitor and application thereof |
| 07/25/2012 | CN102603610A 1,3-dihydro-1-oxo-2H-isobenzazole compounds as well as preparation method and use thereof |
| 07/25/2012 | CN102600316A Chinese medicinal herb preparation for treating closed injury and preparation method thereof |
| 07/25/2012 | CN102600226A Method for extracting serrate clubmoss herb huperzia total alkali |
| 07/25/2012 | CN102178918B Externally applied Chinese medicine for treating sprain |
| 07/25/2012 | CN102154300B Conus lividus neurotoxin and coding sequence and use thereof |
| 07/25/2012 | CN102058814B General flavone extractive of four medicaments including grassleaf sweetflag rhizome and preparation method thereof |
| 07/25/2012 | CN101987135B Medicine for treating tetanus and preparation method thereof |
| 07/25/2012 | CN101972240B Modafinil composition |
| 07/25/2012 | CN101921266B 3,4,6-triaryl-[1,3]-oxazine compound as well as preparation method and application thereof |
| 07/24/2012 | US8227620 Pharmaceutical compounds |
| 07/24/2012 | US8227484 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 07/24/2012 | CA2476065C Inhibitors of histone deacetylase |
| 07/24/2012 | CA2412172C 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof |
| 07/24/2012 | CA2411584C Differential diagnosis of neurological diseases |
| 07/19/2012 | WO2012097330A2 Compositions and methods for treating degenerative muscle conditions |
| 07/19/2012 | WO2012097093A2 Novel wnt compositions and therapeutic uses of such compositions |
| 07/19/2012 | WO2012097057A2 Methods, compositions and kits for modulating trans-differentiation of muscle satellite cells |
| 07/19/2012 | WO2012096458A2 Process for preparation of phenyl carbamate derivatives |
| 07/19/2012 | WO2012095853A1 Modified release formulations comprising sip receptor modulators |
| 07/19/2012 | WO2012064090A3 Chemical preparation method of skeletal muscle-derived multipotent cells and use thereof |
| 07/19/2012 | US20120184612 Compositions and Methods Relating to Carotenoids |
| 07/19/2012 | US20120184569 A3 adenosine receptor agonists and antagonists |
| 07/19/2012 | US20120184533 Small molecule inhibitors of parp activity |
| 07/19/2012 | US20120184517 Treatment of diseases with altered smooth muscle contractility |
| 07/19/2012 | US20120183611 Oral pharmaceutical composition comprising diclofenac |
| 07/19/2012 | US20120183543 Diagnostic biomarkers for fibrotic disorders |
| 07/19/2012 | US20120183524 Molecular targets for treatment of inflammation |
| 07/19/2012 | US20120183520 Minimally invasive methods for treating dysfunction of cardiac muscle |
| 07/19/2012 | US20120183510 High-throughput culture and transfer device and method |
| 07/19/2012 | CA2824235A1 Novel wnt compositions and therapeutic uses of such compositions |
| 07/19/2012 | CA2815460A1 Process for preparation of phenyl carbamate derivatives |
| 07/18/2012 | EP2475427A1 Actriib antagonists and dosing and uses thereof |
| 07/18/2012 | EP2475369A1 Use of steroid compounds for inflammatory and autoimmune disorders |
| 07/18/2012 | EP1437961B1 Methods of suppressing microglial activation |
| 07/18/2012 | CN1440408B Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 07/18/2012 | CN102596949A 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 07/18/2012 | CN102584997A Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 07/18/2012 | CN102584976A Human serum amyloid A1 and preparation method and application thereof |
| 07/18/2012 | CN102579978A External traditional Chinese medicine composition for treating scapulohumeral periarthritis |
| 07/18/2012 | CN102579555A Application of injection-used fat emulsion in medicine preparation for antagonizing general anesthesia medicine effect |
| 07/18/2012 | CN102008439B Curcumin coated liposome preparation and preparation method thereof |
| 07/18/2012 | CN101880283B Azaindole kinase inhibitors |
| 07/18/2012 | CN101511871B Anti-myostatin antibodies |
| 07/18/2012 | CN101440124B Methods for preventing mitochondrial permeability transition |